Published in Ann Intern Med on April 01, 1968
Myxedema coma: a new look into an old crisis. J Thyroid Res (2011) 1.42
Thryroid hormones and hematological indices levels in thyroid disorders patients at moi teaching and referral hospital, Western kenya. ISRN Endocrinol (2013) 0.76
Thyroid disease in the elderly--missed diagnosis or overdiagnosis? West J Med (1985) 0.75
Folate sensitive site at 10q23 and its expression as a deletion. J Med Genet (1987) 0.75
Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma. Clin Case Rep (2017) 0.75
Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med (1994) 4.86
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA (1999) 3.56
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med (1989) 3.32
2.5-million-year-old stone tools from Gona, Ethiopia. Nature (1997) 3.20
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol (1994) 2.82
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell (1991) 2.48
Magnetic-susceptibility measurement of human iron stores. N Engl J Med (1982) 2.35
Is blockade of pancreatic lipase the answer? Am J Clin Nutr (1999) 2.34
Emergence of resistance after spectinomycin treatment for gonorrhoea due to beta-lactamase producing strain of Neisseria gonorrhoeae. Br Med J (Clin Res Ed) (1982) 2.29
The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2005) 2.17
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
Mass-independent sulfur of inclusions in diamond and sulfur recycling on early Earth. Science (2002) 2.08
Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06
Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. Cancer Res (1994) 1.99
Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve (1983) 1.99
Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain (2007) 1.91
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology (1989) 1.90
Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol (1993) 1.76
Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron (1992) 1.75
Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol (1994) 1.68
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain (2009) 1.65
Leucine incorporation into mixed skeletal muscle protein in humans. Am J Physiol (1988) 1.62
Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol (1996) 1.60
Filtration characteristics of sickle cells: rates of alteration of filterability after deoxygenation and reoxygenation, and correlations with sickling and unsickling. J Lab Clin Med (1970) 1.56
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial. Ann Intern Med (1999) 1.53
Development of malabsorption and nutritional complications in simian immunodeficiency virus-infected rhesus macaques. AIDS (1994) 1.51
Studies on the pathogenesis of alcohol-induced sideroblastic bone-marrow abnormalities. N Engl J Med (1970) 1.47
Radiation therapy for AIDS-related Kaposi's Sarcoma. Int J Radiat Oncol Biol Phys (1990) 1.47
Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF. Muscle Nerve (1994) 1.44
Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA (1992) 1.43
Complications of parenteral nutrition. Am J Surg (1986) 1.43
Andersen's syndrome: a distinct periodic paralysis. Ann Neurol (1997) 1.42
Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann Intern Med (1970) 1.41
Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology (1991) 1.40
Observation of an antimatter hypernucleus. Science (2010) 1.38
Biennial survey of physician clinical-nutrition training programs. Am J Clin Nutr (1993) 1.37
Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol (1993) 1.37
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology (1994) 1.33
Hereditary paroxysmal ataxia: response to acetazolamide. Neurology (1978) 1.33
Intestinal malabsorption in folate-deficient alcoholics. Gastroenterology (1973) 1.33
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther (1995) 1.31
Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis. Ann Neurol (2001) 1.31
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol (1994) 1.28
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol (1976) 1.28
The sideroblastic anemias. Semin Hematol (1970) 1.25
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord (1997) 1.24
Late onset hereditary distal myopathy. Neurology (1974) 1.24
Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology (1991) 1.23
Hereditary myokymia and periodic ataxia. J Neurol Sci (1975) 1.21
Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol (1985) 1.20
Sickle cell anemia and trait in southern India: further studies. Am J Hematol (1979) 1.20
Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann Neurol (2000) 1.17
Hereditary complement (C2) deficiency with dermatomyositis. Am J Med (1975) 1.17
Distal myopathy: electron microscopic and histochemical studies. Neurology (1977) 1.17
Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor epsilon subunit. Neuron (1998) 1.17
Social immunity in honeybees (Apis mellifera): transcriptome analysis of varroa-hygienic behaviour. Insect Mol Biol (2011) 1.17
The control of venereal disease. Br J Vener Dis (1975) 1.16
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol (1991) 1.16
Determination of serum and blood pyridoxal phosphate concentrations with purified rabbit skeletal muscle apophosphorylase b. J Lab Clin Med (1969) 1.16
Cardiac conduction in myotonic dystrophy. Am J Med (1975) 1.16
Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med (1968) 1.16
Genetics and physiology of the myotonic muscle disorders. N Engl J Med (1993) 1.16
Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol (1996) 1.15
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology (2001) 1.15
Assessment of bone marrow and body iron stores: old techniques and new technologies. Semin Hematol (1981) 1.15
End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Ann Neurol (1996) 1.15
Acquired sixth-nerve paresis in children. Arch Ophthalmol (1970) 1.14
Reversible megaloblastic and sideroblastic marrow abnormalities in alcoholic patients. Br J Haematol (1969) 1.14
Association of inflammatory bowel disease and large vascular lesions. Gastroenterology (1976) 1.14
Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. Arch Neurol (1987) 1.14
Varying intensity of postremission therapy in acute myeloid leukemia. Blood (1992) 1.13
Distribution of ethanol in the human gastrointestinal tract. Am J Clin Nutr (1973) 1.13
Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology (1976) 1.13
Note on plasma exchange therapy in Refsum's disease. Adv Neurol (1978) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Muscle pain, fatigue, and mitochondriopathies. N Engl J Med (1999) 1.12
Renal involvement in Refsum's disease. Am J Med (1981) 1.11
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Non-volatile fatty acids in the diagnosis of non-specific vaginitis. J Clin Pathol (1983) 1.11
An ultrastructural study of subacute combined degeneration of the spinal cord in vitamin B12-deficient rhesus monkeys. J Neuropathol Exp Neurol (1978) 1.11
Episodic movement disorders as channelopathies. Mov Disord (2000) 1.10
Effect of prednisone on protein metabolism in Duchenne dystrophy. Am J Physiol (1995) 1.09
Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology (1995) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
The excretion of foriminoglutamic acid and urocanic acid after partial gastrectomy. Lancet (1966) 1.07
Intracellular pteroylpolyglutamate hydrolase from human jejunal mucosa. Isolation and characterization. J Biol Chem (1986) 1.07
Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium. Ann Neurol (1998) 1.07
Rectal complications after perineorrhaphy and episiotomy. Arch Surg (1966) 1.06
Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group. Neurology (1994) 1.06
Goblet cell mucus in the small intestine. Findings after net fluid production due to cholera toxin and hypertonic solutions. Johns Hopkins Med J (1972) 1.06
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology (1996) 1.04
Decreased jejunal uptake of labeled folic acid ( 3 H-PGA) in alcoholic patients: roles of alcohol and nutrition. N Engl J Med (1971) 1.03
Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch Neurol (1987) 1.02
Orbicularis fatigue: the 'peek' sign of myasthenia gravis. Arch Ophthalmol (1979) 1.02
Radiosensitization of hypoxic mammalian cells by diamide. I. Effects of experimental conditions on survival. Radiat Res (1975) 1.01